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Abstract
Food is a basic requirement for human life and well-being. On the other hand, 
diet is necessary for growth, health and defense, as well as regulating and assisting 
the symbiotic gut microbial communities that inhabit in the digestive tract, referred 
to as the gut microbiota. Diet influences the composition of the gut microbiota. The 
quality and quantity of diet affects their metabolism which creates a link between 
diet. The microorganisms in response to the type and amount of dietary intake. 
Dietary fibers, which includes non-digestible carbohydrates (NDCs) are neither 
neither-digested nor absorbed and are subjected to bacterial fermentation in the 
gastrointestinal tract resulting in the formation of different metabolites called 
SCFAs. The SCFAs have been reported to effect metabolic activities at the molecu-
larlevel. Acetate affects the metabolic pathway through the G-protein-coupled 
receptor (GPCR) and free fatty acid receptor2 (FFAR2/GPR43) while butyrate and 
propionate transactivate the peroxisome proliferator-activated receptors (PPARγ/
NR1C3) and regulate the PPARγ target gene Angptl4 in colonic cells of the gut. The 
NDCs via gut microbiota dependent pathway regulate glucose homeostasis, gut 
integrity and hormone by GPCR, NF-kB, and AMPK-dependent processes. In this 
chapter, we will focus on dietary fibers, which interact directly with gut microbes 
and lead to the production of metabolites and discuss how dietary fiber impacts gut 
microbiota ecology, host physiology, and health and molecule mechanism of dietary 
fiber on signaling pathway that linked to the host health.
Keywords: dietary fibe, gut microbiota ecology, host health, signaling pathway, 
molecule mechanism
1. Introduction
The human gut harbors a plethora of a complex community of micro-organisms 
that are vital for host development and physiology. This community of microbes 
inhabiting the gut called “gut microbiota” represents a mutualistic symbiotic rela-
tionship with the host [1]. The host creates a stable environment for the microbes 
while the microbes offer the host with an array of functions such as digestion of 
complex dietary macronutrients, minerals and vitamins production, pathogen 
protection, and immune system maintenance. Studies have shown that the gut 
microbiota comprises of about 3.8 × 1013 microorganisms [2] belonging to a wide 
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spectrum of about 160 recognized gut bacterial species [3]. Generally, the opus of 
the gut microbiota is observed to be comparable in all healthy individuals, however 
the presence of different microbial species is determined by an individual’s dietary 
habits, dietary patterns and lifestyle [4]. Dietary fibers (DFs) are vital modulators 
of the gut microbiota composition which directly impacts individual biological pro-
cesses and homeostasis via the metabolites, a consequent of microbial fermentation 
of nutrients such as, short-chain unsaturated fats (SCFAs) [5]. The gut microbiota 
plays a key and essential role in the metabolization of DFs including non-digestible 
carbohydrates (NDCs), proteins and peptides, which has escape digestion by host 
enzymes in the upper gut and absorption in the lower digestive tract. These dietary 
constituents, are then subjected to fermentation by the microbiota in the cecum 
and colon (Macfarlane and Macfarlane, 2012) resulting in the production different 
metabolites called SCFAs varying in carbon number which includes mainly acetate 
(60%), propionate (25%) butyrate (15%) and methane (CH4), carbon dioxide 
(CO2) gases [6] which are known to have beneficial effects by behaving as signal-
ing molecules via different pathways. From among the different SCFAs produced 
Acetate is the most abundant and it is used by many gut commensals to produce 
propionate and butyrate in a growth-promoting cross-feeding process. Moreover, 
the SCFA, have been shown a to regulate metabolic activities. Acetate affects the 
metabolic pathway through the G protein-coupled receptor (GPCR) and free fatty 
acid receptor 2 (FFAR2/GPR43) while butyrate and propionate transactivate the 
peroxisome proliferator-activated receptorsᵧ (PPARᵧ/NR1C3) and regulates the 
PPARᵧ target gene Angptl4 in colonic cells of the gut. The FFAR2 signaling pathway 
regulates the insulin-stimulated lipid accumulation in adipocytes and inflammation 
however peptide tyrosine-tyrosine and glucagon-like peptide 1 regulate appetite. 
The NDCs via microbiota dependent pathway regulate glucose homeostasis, gut 
integrity, and hormone by GPCR, NF-kB, and AMPK-dependent processes. Hence 
in this chapter, emphasis is given to address the effects of dietary fibers metabolites 
as prime signaling molecules, through different signaling pathways and their link 
between gut microbiota and the host health.
2. Dietary fibers (DFs), gut microbiota and SCFAs metabolites
2.1 Dietary fibers (DFs)
Dietary fibles defined by codex alimentarius commission (2009) are edible 
carbohydrate polymers with varying monomeric units that are impervious to the 
host digestive enzymes and thus has escape absorption in the small intestines. These 
includes, (1) edible naturally occurring carbohydrate polymers present in foods 
such as fruits, vegetables, legumes, and cereals (2) edible carbohydrate polymers 
obtained from food raw materials by physical, enzymatic, and chemical means and 
(3) synthetic carbohydrate polymers. In addition, DFs are further divided either into 
polysaccharides (non-starchpolysaccharides [NSPs], resistant starch [RS], and resis-
tant oligosaccharides [ROs]) or into insoluble and soluble forms [7]. Soluble fibers 
are fermented by the gut bacteria giving rise to metabolites such as short-chain 
fatty acids (SCFAs), insoluble forms of fibers such as cellulose and hemi-cellulose 
may or slowly digested by the gut bacteria and contributes to a fecal bulking effect, 
as they reach the colon. Delay absorption of glucose and lipids influencing post-
prandial metabolism on the other hand are caused by most soluble NSPs, especially 
polymers with high molecular weight such as guar gum, certain pectins, b-glucans, 
and psyllium, are viscous, meaning that they are able to form a gel structure in the 
intestinal tract that can [7]. Food sources such as legumes, vegetables, nuts, seeds, 
3
Signaling Pathways Associated with Metabolites of Dietary Fibers Link to Host Health
DOI: http://dx.doi.org/10.5772/intechopen.99586
fruits, and cereals forms the sources of soluble and insoluble fibers whereas RS can 
only be found in starchy foods such as legumes, tubers, cereals, and fruitlike green 
bananas, whereas pectin’s are more abundant in fruits and some vegetables, whereas 
b-glucans are found in cereals [8]. Recently, due to low consumption of DFs in the 
Industrialized Western world Fortification of foods with extracted or synthesized 
non-digestible carbohydrates is carried out as a strategy to increase fiber intake. 
Besides, a wide range of commercial DFs are currently available [9] worldwide, 
called “prebiotics” on the fact that they exert health benefits by selectively induc-
ing beneficial bacterial populations in the gut. However, contrastingly, studies 
have reported that irrespective of the types of fibers, virtually all fibers will induce 
specific shifts in microbiota composition as a result of competitive interactions, 
and which of these compositional shifts may be beneficial for health, has not yet 
been established [10]. Furthermore, the mechanisms that have been established to 
be beneficial to health, is not calculative on the selective utilization of the carbohy-
drates but on an integrative effect of bacterial fermentation, producing metabolic 
compounds (e.g., SCFAs) [11], physiological changes (pH lowering), or protection 
of the mucus layer [12, 13]. Hence, a change in the emphasis of the prebiotic concept 
away from the selective effect of specific dietary components on gut microbial 
communities towards the effects of ecological and functional consequences of fiber 
fermentation, is more significant for host physiology and health [10].
2.2 Gut microbiota
Microorganisms including several species of bacteria, yeast, and viruses make 
up the Gut microbiota. Out of the different Bacterial phyla, a few phyla represented, 
by about 160 species [14] composed the gut microbiota. Some of the dominant 
gut microbial phyla are Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, 
Fusobacteria, and Verrucomicrobia, with phyla Firmicutes and phyla Bacteroidetes 
[15] making up to 90% of gut microbiota. Clostridium, Enterococcus, Lactobacillus, 
Bacillus, and Ruminicoccus are among the more than 200 genera in the Firmicutes 
phylum. Clostridium genera represent 95% of the Firmicutes phyla. Phylum 
Bacteroidetes consists of Bacteroides and Prevotella as predominant genera. The 
Actinobacteria a less abundant phylumis mainly represented by the Bifidobacterium 
genus [15]. Besides, the gut microbiome is to a very large extent affected by dietary 
administration of fiber, which alters the gut microbiota by providing substrates 
for microbial growth, and expansion of their populations [7]. The possession of 
different enzymes, about 130 glycoside hydrolase, 22 polysaccharidelyase, and 
16 carbohydrate esterase enzyme families, allows the gut microbiome to switch 
between different energy sources of fibers depending on their availability [16]. 
Bacteria such as Firmicutes and Actinobacteria has been found to be prime spe-
cies, which initiates the degradation of complex substrates [7]. Species such 
as Bifidobacteriumadolescentis, Ruminoccocusbromii, Eubacteriumrectale, and 
Parabacteroides distasonisplay significant roles in degrading resistant Starch [1, 17]. 
The consumption of galactooligosaccharides mainly induces Bifidobacterium spe-
cies possessing the enzymatic machinery to utilize the substrate [18]. Reports have 
also suggested that, degradation of complex substates, occurs in a cascade where, 
different species will contribute equally at different stages towards production of 
metabolites [7]. Primary fiber degraders are species that initiate the utilization 
of a complex fiber through what can be considered a “guild” of species [19] or a 
keystone species. Although R. bromii does not make butyrate, it is considered a 
keystone species for the breakdown of RS and contributes significantly to butyr-
ate generation in the colon. Other dietary fiber types are expected to have similar 




Dietary fibers, are metabolized by the microbiota in the cecum and colon [20] 
resulting in the formation of major products such as particular, acetate, propionate, 
and butyrate [21]. However, studies have reported that, microbes can utilize amino 
acids from dietary proteins and triglycerols from fats [22, 23] to facilitate dimin-
ished supply of dietary fermentable fibers resulting in reduced fermentative activity 
and formation of SCFAs as minor end products [24]. Although, protein fermenta-
tion was observed to the SCFA pool but, however dietary proteins mostly give rise 
to branched-chain fatty acids such asisobutyrate, 2-methylbutyrate, and isovalerate, 
[25] which are may have a concerning effect as a result of insulin resistance [26].
Acetate (C2) is a major SCFA metabolite produced from pyruvate. Many gut 
bacteria produce Acetate from pyruvate via acetyl-CoA or the Wood-Ljungdahl 
pathway, which produces acetate via two branches: (1) the C1-body branch (also 
known as the Eastern branch) via CO2 reduction to formate and (2) the carbon 
monoxide branch (also known as the Western branch) via CO2 reduction to CO, 
which is then combined with a methyl group. Propionate is created when succinate 
is converted to methylmalonyl-CoA through the succinate pathway. Furthermore, 
propionate, can also be synthesized from acrylate using lactate as a precursor via the 
acrylate pathway [27] and via the propanediol pathway using deoxyhexose sugars as 
substrates [28]. Butyrate, the third main SCFA, is produced by the condensation of 
two molecules of acetyl-CoA and subsequent reduction to butyryl-CoA, which can 
then be converted to butyrate by phosphotrans butyrylase and butyrate kinase via 
the classical pathway [29]. The butyryl-CoA: acetate CoA-transferase enzyme can 
also convert butyryl-CoA to butyrate [30]. Besides, reports have also shown that 
some microbes can use both lactate and acetate to synthesize butyrate. Butyrate can 
also be produced from proteins via the lysine pathway, according to a recent analysis 
of metagenome data [31], implying that microorganisms in the gut can adjust to 
dietary changes in order to sustain the synthesis of important metabolites like 
SCFAs. SCFA levels vary along the length of the gut, with the highest concentra-
tions in the cecum and proximal colon and decreasing towards the distal colon [21].
3.  Dietary fibers metabolites signaling mechanism and their health 
implications
3.1 Molecular mechanism of dietary fibers (DFs) and its metabolites
The metabolites of dietary fibers (DFs) are SCFAs that play a significant role 
in metabolic diseases prevention and treatment along with some contradictory 
research finding [32]. The SCFAs formate, lactate, acetate, propionate, and butyrate 
are produces by the saccharolytic fermentation of the dietary fibrous [33] which 
have a significant role in the maintenance of health by reducing the chances of 
development of different disease.
World Health Organization have recommended daily intake of dietary fiber 
20 g per 1000 kcal consumed for adults human being and this (20 g per 1000 kcal) 
quantity of dietary fiber is full filled by the daily consumption 400 g per day of 
fresh vegetables, fruits and grains (https://www.who.int/news-room/fact-sheets/
detail/healthy-diet). Modern life style, dietary pattern, seasonality, stress, habitat, 
consumption of antibiotics and disease cause a drastic change in dietary pattern of 
individual’s finally leads to gut microbial alteration [34] that influence production of 
SCAFs. The various physiological functions in the gut (including adding the energy 
to colonocytes, maintaining their mobility, blood flow, and regularize the movements 
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of electrolytes and nutrients within the lumen) activate and modulate by SCAFs [35]. 
Colonic cell proliferation, differentiation and integrity mentioned by butyrate along 
with the major and preferred metabolic substrate for colonocytes 60–70% energy 
requirement [36]. Propionate maintains glucose homeostasis by gluconeogenic path-
way [37]. The expression of leptin has enhanced by propionate and acetate. Leptin is 
a potent anorectic hormone, in adipocytes [38]. Acetate is a lipogenic SCFAs, reduced 
levels of acetate would result in decreased lipogenesis [37]. In the rat hepatocytes, 
acetate act as de novo lipogenesis and cholesterol synthesis, and these two pathways 
are to be inhibited by propionate [39]. The increased levels of propionate SCFAs 
would assist in the inhibition of acetate conversion into lipid in adipose tissue and the 
liver. The DFs via gut microbiota increase the rate of acetate synthesis while reduc-
ing the level of propionate in cells [40]. Acetate SCFAs is inversely related to plasma 
insulin levels [41] and acetate also activates leptin secretion in murine adipocytes [42].
High-fat diet-fed rats have increased acetate (C2) production due to gut micro-
biota that leads to ghrelin secretion and glucose-stimulated insulin secretion by 
activation of the parasympathetic nervous system (PNS), apart from these high 
calorically dense diet through gut microbiota-brain-β-cell axis promotes obesity and 
health complications by regimenting glucose and lipids homeostasis [43].
New study finding by many researchers groups have suggested that [44, 45] 
the loss of gut microbiota species from the colonic microbiota is associated to 
consumption of the high-fat, low-dietary fiber diets and other nutrient intake and 
diversity of gut microbiome [46, 47]. The fermentable dietary fibers directly govern 
the diversity of the gut microbiota [48], SCFAs regulate the different physiological 
activity of host. The majority of SCFAs transported across the mucosa by active 
transport, mediated by two receptors. The monocarboxylate transporter 1 (MCT-1) 
and the sodium-coupled monocarboxylate transporter 1 (SMCT-1) receptors. Direct 
inhibition of histone deacetylases HDACs to directly regulate gene expression and 
SCFA also effects signaling through G-protein-coupled receptors (GPCRs), this 
may influence host physiology by modulate biological responses of the host.
3.2 SCFAs sensing signaling pathway
All physiological activities occurring in the body are gut metabolites driven and 
SCFAs are connecting the link between the gut immunity with microbiota. The 
crucial role of SCFA has been signified in shaping and regulating both local and 
peripheral immune systems that respond to host metabolism via inflammatory 
pathways. Therefore, SCFAs modulate functions of the different systems including 
the enteric, nervous, endocrine, and blood vascular system serving as a key factor to 
regulate metabolic disorders and immunity. The dietary fibers metabolites exerted 
effects via their receptors, like the G protein-coupled receptor (FFAR3/GPR41 and 
FFAR2/GPR43 and GPR109a) through the inhibition of histone deacetylases and 
the activation of G-protein coupled receptors [32, 49].
3.3 SCFAs sensing signaling pathway in immunological responses
Gut bacteria produced SCFAs from indigestible saccharides diet precursors and 
SCFAs transported across the mucosa by active transport mediated by two receptors, 
monocarboxylate transporter 1 (MCT-1) and sodium-coupled monocarboxylate 
transporter 1 (SMCT-1) receptors which influence host physiological functions and 
modulate biological responses of the host. The main mechanism is direct inhibition 
of histone deacetylases (HDACs) to directly regulate gene expression. HDACs remove 
acetyl groups (deacetylation) from lysine residues of histones [50]. Transcription 
of genes is enhanced through inhibition of HDACs function by increasing histone 
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acetylation. Dietary fibers SCFAs inhibit HDACs activity and therefore suppress 
expression of gene in different cells. Butyrate (C4) SCFAs is the most potent inhibi-
tor of HDACs activity and induces gene activation by facilitating the access of 
transcription factors to promoter region, such kind’s activity of C4 known as an 
epigenetic modification of chromatins [51]. The SCFAs-mediated HDACs inhibi-
tion, acts as an anti-inflammatory immune response mediated by less production of 
inflammatory cytokines IL-8, IL-6, and TNFα [52]. Apart from these butyrate and 
propionate reduced NF-kB activity and inflammatory cytokines [53], showing that 
the anti-inflammatory effects of SCFAs are mediated through the modulation of 
NF-kB signaling pathway. Beside this the SCFAs also affect signaling through GPCRs. 
The SCFAs activate different GPCRs e.g. propionate (C3) is a most potent activator 
of GPR43. The expression of GPR43 has been reported in the entire gastrointestinal 
tract (GIT) along with cells of the immune and nervous systems. In GIT, GPR43 is 
highly expressed in endocrine L-cells of the ileum and colon of intestinal PYY and 
GLP-1 [54] producing cells as well as on colonocytes and enterocytes. The order of 
potency was reported as like propionate >butyrate>acetate for GPR41 receptor [55]. 
The SCFAs control the body weight through the release of leptin in adipose tissue by 
the expression of GPR41 [56]. The SCFAs play crucial role in metabolic functions of 
hepatic cells through the FFAR3 signaling pathway without influencing the intestinal 
environment [57]. Niacin receptor 1 (GPR109a) is activated by C4 at low concentra-
tion while highly expressed in adipocytes with a lesser extent is also expressed on 
immune cells. Activation of GPR109a in adipocytes suppresses lipolysis and the low-
ering of plasma-free fatty acid levels (FFAs) [58]. Through epigenetic mechanisms 
via histone acetylation acetate also increases fatty acid synthesis [59]. Therefore these 
finding could helpful to promote the development of functional foods using SCFAs 
or dietary significance of non-digestible carbohydrates fiber.
3.4 SCFAs sensing signaling pathway in hormone regulation
Gut microbes regulates the host metabolism by secretion of gut hormone. Gut 
microbiota induced signal to nearby intestinal enteroendocrine cells through micro-
bial metabolites of DFs. These enteroendocrine cells release metabolically active 
hormones like GLP-1, PYY, GIP, 5-HT, and CCK which influence feeding behavior, 
glucose metabolism, insulin sensitivity and adiposity. Dietary components also 
impact on the composition of gut microbiota which may have further downstream 
consequences on gut hormone secretion and host metabolism. Enterochromaffin 
cells (EC) of the gut are the main source of serotonin (5-HT, 5-hydroxytryptamine). 
The EC is dispersed throughout the GI tract of the host and constitutes about 
half of all enteroendocrine cells. The gut microbiota influences 5-HT levels in the 
host. The antibiotic-treated mice study showed that significantly lower levels of 
EC cell-derived 5-HT when compared to antibiotic free animals. The EC cells can 
sense microbial metabolites by FFAR2 and FFAR3 signaling mechanisms [60]. PYY 
(Peptide tyrosine-tyrosine) regulates food intake and satiety through activation 
of central G protein-coupled Y2 receptors on neuropeptide Y (NPY) and AgRP 
neurons in arcuate nucleus of hypothalamic part of brain [61]. This is the relay of 
signaling cascade where by appetite-stimulating NPY neurons are suppressed that 
allowing for the activation of the satiety-inducing a-MSH / pro-opiomelanocortin 
(POMC) pathway [62]. The ability of gut microbiota to influence PYY secretion, 
therefore, gut microbiota has significant implications for the development of meta-
bolic disease and obesity. Study reported that oral administration of C4 increased 
circulating PYY level [63] by FFAR2/3 signaling. Glucagon-like peptide 1 (GLP-1) 
augments insulin and inhibits glucagon secretion from the pancreas cells. GLP-1 
inhibits gastric emptying and influences satiety and food intake [64, 65]. Orally 
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administrated sodium butyrate in mice has been shown to transiently increase GIP 
and GLP-1 secretion and GIP level were associated with adiposity reported the 
ileal infusion of acetate, propionate, and butyrate during feeding in pigs, increased 
plasma CCK levels and paradoxically inhibit pancreatic secretion [66]. SCFAs 
are influence insulin function via their receptors [67, 68]. Glucose homeostasis in 
type 2 diabetes mellitus patients managed by fiber reaches diet that alters the gut 
microbiota. The deficiency in SCFAs production in host has associated with type 
2 diabetes by interfering HbA1c levels in circulation [69]. Diet plat a major role in 
gut microbiota composition and gut microbiota regulates metabolism via metabo-
lites produces by plant-based diets and intake of probiotics increases secretion of 
carbohydrate-active enzymes [70] in luminal of GIT.
4. Conclusion
Dietary fibers and its gut microbial metabolite SCFAs have been known to exert 
metabolic benefits to the host [71]. Various health benefits have been reported whereby 
Dietary fibers via SCFA increase plasma SCFA levels to active FFAR3 which has been 
shown to improve hepatic metabolic conditions. Furthermore, Dietary fibers con-
sumption reduced HFD-induced liver weight growth and hepatic TG accumulation, 
as well as a shift in hepatic lipid metabolism. Dietary SCFAs consumption improved 
hepatic metabolic conditions via the FFAR3 signaling pathway. Besides, Dietary fibers 
were reported to shift the gut microbiome towards the production of more butanoate 
which is accompanied by up-regulation of microbiota and AMP-activated protein 
kinase (AMPK)-dependent gene expression which contributes to intestinal integrity 
and homeostasis by affecting metabolism, transporter expression. In addition, micro-
bial metabolite SCFAs derived from microbial fermentation of dietary fibers are likely 
to have more broad impacts on various aspects of host physiology including health. 
Hence, Diet plays a pivotal role and is key as they have a significant impact on the 
composition, variety, and richness of the gut microbiota which directly determines the 
formation of essential SCFAs metabolites. Different aspects of the diet have a time-
dependent effect on gut bacterial ecosystems. Long-term dietary patterns, particularly 
high protein and animal fat intake, have been demonstrated to diminish the number of 
beneficial microorganisms, which has been linked to host health.
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